RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST.
Chung MH, Aimaier R, Yu Q, Li H, Li Y, Wei C, Gu Y, Wang W, Guo Z, Long M, Li Q, Wang Z.
Chung MH, et al. Among authors: wang w, wang z.
Cell Oncol (Dordr). 2023 Oct;46(5):1399-1413. doi: 10.1007/s13402-023-00819-4. Epub 2023 Apr 22.
Cell Oncol (Dordr). 2023.
PMID: 37086345